CRISPR Gene Editing Newsletter
Issue #54September 14, 20267 studies

Four blood disorder patients across three continents stopped needing transfusions after base editing

Gene editing just had a quietly remarkable week — not in mice, not in theory, but in actual patients with blood disorders across three different genetic backgrounds.

The tools are getting sharper, the targets are getting bigger, and one team figured out how to edit HIV out of monkey brains.

🩸 A base editor works across borders — and blood types

  • Researchers treated four patients — one with sickle cell disease in Africa, three with a severe form of thalassemia in South and Southeast Asia — using a "transformer base editor" (tBE) designed to switch fetal hemoglobin back on. All four stopped needing blood transfusions.
  • After more than 12 months of follow-up, editing held, fetal hemoglobin stayed high across all red blood cells, and the sickle cell patient had zero vaso-occlusive episodes. No off-target mutations, no malignancies, no deaths.
  • These patients carried mutations that differ from the Chinese cohort treated in earlier trials — meaning the same editor worked across genetically distinct populations.

Why it matters: Blood disorders like sickle cell disease affect millions of people with wildly different underlying mutations. A single editing approach that works across genetic backgrounds is the difference between a niche fix and a scalable treatment.

🥇 Top 1% journal 🔗 Cell stem cell Journal Article 🗓️ Sep 7

Key Findings

🧠 CRISPR reached HIV hiding in primate brains

  • HIV-like virus (SIV) persists in multiple brain regions of monkeys even when antiretroviral therapy suppresses it elsewhere — and that's a problem, because the brain may seed viral rebound.
  • Researchers delivered CRISPR via a viral vector (AAV9) intravenously in rhesus macaques and detected measurable proviral editing across anatomically distinct brain sites, the first evidence this approach can reach the central nervous system reservoir.
💡 Systemic CRISPR delivery edited HIV-like DNA inside primate brain tissue
🥉 Top 5% journal 🔗 Molecular therapy. Nucleic acids Journal Article 🗓️ Sep 11

🔬 A new off-target detector catches what others miss

  • Tracking-seq2 combines two additional steps — exonuclease treatment and a pathway inhibitor — with an existing method to catch off-target edits in primary human cells like T cells and blood stem cells with sensitivity matching or exceeding current best-in-class tools.
  • A notable finding: genomic variation between individuals produced meaningfully different off-target profiles, suggesting that safety testing on one person's cells may not predict another's.
💡 Individual genetic variation changes where CRISPR cuts unintentionally — personalized safety checks may be necessary
🥈 Top 2% journal 🔗 Nature communications Journal Article 🗓️ Sep 9

🌾 Prime editing rewrote three genes in alfalfa at once

  • For the first time, researchers used prime editing — a more precise, cut-free genome editing method — to simultaneously modify three genes in alfalfa, producing plants resistant to two different classes of herbicides.
  • Alfalfa is the world's most widely grown forage crop, and it currently lacks herbicide-resistant varieties, making weed control a serious yield problem. Multi-gene prime editing in this crop had not been demonstrated before.
💡 Multi-gene prime editing in alfalfa opens a new path for weed-resistant forage crops
🥉 Top 5% journal 🔗 Plant biotechnology journal Journal Article 🗓️ Sep 10

💊 An upgraded base editor cut cholesterol by a third in humanized mice

  • A redesigned version of the transformer base editor — called etBE — showed up to 35-fold higher editing efficiency than its predecessor while maintaining a low off-target profile.
  • Delivered via a dual viral vector system targeting a well-known cholesterol gene (PCSK9) in humanized mice, etBE achieved up to 35% in-vivo editing, reducing a key cholesterol-related protein by 24% and LDL cholesterol by 33%.
💡 A more efficient base editor cut LDL cholesterol by a third in a mouse model
🥈 Top 2% journal 🔗 Advanced science (Weinheim, Baden-Wurttemberg, Germany) Journal Article 🗓️ Sep 11

🦠 A one-pot CRISPR test detected two respiratory viruses in 15 minutes

  • A diagnostic system called MS-CRISPR introduced deliberate mutations into the guide RNA scaffold to slow down CRISPR's cleavage speed — preventing it from burning through amplified DNA before enough had accumulated.
  • The result: a closed-tube, 15-minute test detecting both SARS-CoV-2 and influenza A at 1 copy per microliter, with 100% sensitivity and specificity in clinical patient samples, readable via a paper lateral-flow strip.
💡 Slowing CRISPR's cleavage kinetics made a faster, more sensitive one-pot viral test
🔗 Proc Natl Acad Sci U S A Journal Article 🗓️ Sep 9

🧬 A genome-wide brain screen mapped which genes neurons can't live without

  • Researchers ran CRISPR interference screens across four neuron types at three life stages — from young to aging — in living mice, identifying 269 genes essential to neurons that standard lab cell screens had missed.
  • Aging neurons showed new dependencies on mitochondrial and protein-production pathways, mirroring gene expression shifts seen in aging human brains. Two genes showed opposite essentiality in excitatory versus inhibitory neurons.
💡 Aging mouse neurons depend on different genes than young ones — and the pattern echoes human brain aging
🔗 Neuron Journal Article 🗓️ Sep 9

Implications

Base editing is moving from proof-of-concept to cross-population medicine, CRISPR diagnostics are approaching field deployment, and genome-wide screens are building functional maps of the brain. The unresolved question: whether off-target profiles that vary between individuals will require patient-by-patient safety validation before any of these therapies can scale.

Studies in this issue

Primary sources used for this newsletter.

  1. Using precise gene editing to treat inherited blood disorders affecting β-globin in different genetic backgrounds
    main storyCell stem cell2026-09-07PMID 42705233
  2. Editing brain viral reservoirs in treated SIV-infected rhesus macaques
    key findingMolecular therapy. Nucleic acids2026-09-11PMID 42724751
  3. Creating Herbicide-Resistant Alfalfa Using Precise Gene Editing
    key findingPlant biotechnology journal2026-09-10PMID 42720300
  4. Changing crRNA structure to balance reaction speeds improves one-step CRISPR-Cas12 diagnostic tests
    key findingProceedings of the National Academy of Sciences of the United States of America2026-09-09PMID 42715083
  5. Improved Transformer-Based Tool for More Efficient DNA Editing
    key findingAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026-09-11PMID 42723179
  6. Highly sensitive detection of unintended CRISPR gene editing effects using Tracking-seq2
    key findingNature communications2026-09-09PMID 42716927
  7. Mapping how different brain cell types and ages affect neuron vulnerability using gene-silencing screens in mice
    key findingNeuron2026-09-09PMID 42716014

Continue reading

All CRISPR Gene Editing issues